Wordt geladen...
PATH-39. A NEW MOLECULAR PROGNOSTIC MARKER FOR MALIGNANT GLIOMA
Glioma is the most popular primary CNS tumor and especially, Glioblastoma multiforme (GBM), WHO Grade IV glioma, is the worst prognostic tumor in all systemic cancers. Despite maximum resection followed by chemoradiotherapy, the overall median survival is only about 15 months. To date, molecular res...
Bewaard in:
| Gepubliceerd in: | Neuro Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Oxford University Press
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692468/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.729 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|